Ex parte GAFFAR et al. - Page 2




            Appeal No. 1995-4903                                                                         
            Application No. 07/926,016                                                                   


                  This is an appeal under 35 U.S.C. § 134 from the                                       
            examiner’s refusal to allow claims 1 through 16 which are all                                
            of the claims  in the application.                                                           


                                            THE INVENTION                                                
                  Appellants’ invention is directed to an oral care                                      
            composition containing effective amounts of azacycloalkane-2,-                               
            diphosphonate which is an anticalculus agent and an effective                                
            amount of a bis(halo phenyl) antimicrobial agent.  The                                       
            composition also contains a toxicologically acceptable oral                                  
            carrier.                                                                                     


                                              THE CLAIMS                                                 
                  Claims 1 and 15 are illustrative of appellants’ invention                              
            and are reproduced below.                                                                    
                  1.    An oral care composition comprising                                              
                  (a) an effective amount of a source of an                                              
            azacycloalkane-2,-diphosphonate anion as an anticalculus                                     
            agent;                                                                                       
                  (b) an effective amount of a bis(halo phenyl)                                          
            antimicrobial agent; and                                                                     
                  (c) a toxicologically acceptable oral carrier.                                         

                                                   2                                                     





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007